1478833

Związek C związany z orlistatem

United States Pharmacopeia (USP) Reference Standard

• Synonim(y): Triphenylphosphine oxide, Ph₃PO, TPPO, Triphenyl phosphorus oxide, Triphenylphosphine monoxide
• Wzór liniowy: (C₆H₅)₃PO
• Numer CAS: 791-28-6
• Masa cząsteczkowa: 278.28
• UNSPSC Code: 41116107
• NACRES: NA.24
• PubChem Substance ID: 329750619
• MDL number: MFCD00002080
• Beilstein/REAXYS Number: 745854

Właściwości

• grade: pharmaceutical primary standard
• agency: USP
• API family: orlistat
• form: crystalline
• manufacturer/tradename: USP
• mp: 150-157 °C (lit.)
• application(s): USP Biologics; pharmaceutical (small molecule)
• format: neat
• SMILES string: O=P(c1ccccc1)(c2ccccc2)c3ccccc3
• InChI: 1S/C18H15OP/c19-20(16-10-4-1-5-11-16,17-12-6-2-7-13-17)18-14-8-3-9-15-18/h1-15H
• InChI key: FIQMHBFVRAXMOP-UHFFFAOYSA-N

Opis

General description

Orlistat Related Compound C is a chemical impurity related to the active pharmaceutical ingredient Orlistat. It is a by-product that can be formed during the synthesis of Orlistat and is closely monitored in biologic formulations. The presence of this compound is typically controlled, as it may impact the safety, efficacy, and regulatory compliance of the final product.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Wzorzec referencyjny Orlistat Related Compound C USP, przeznaczony do stosowania w określonych testach jakości i oznaczeniach, jak określono w kompendiach USP. Również do użytku z monografiami USP, takimi jak:

• Latanoprost
• Orlistat

Analysis Note

Produkty te są przeznaczone wyłącznie do testów i oznaczeń. Nie są one przeznaczone do podawania ludziom lub zwierzętom i nie mogą być stosowane do diagnozowania, leczenia lub wyleczenia jakichkolwiek chorób.

Other Notes

Ten produkt jest częścią USP Biologics Program.

Sales restrictions may apply.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pha

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS07
• signalword: Warning
• hcodes: H302,H412
• pcodes: P264 - P270 - P273 - P301 + P312 - P501
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Chronic 3
• Klasa składowania: 11 - Combustible Solids
• wgk: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable